Gateway Advisory, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Gateway Advisory, LLC

  • $558 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$182.66 - $235.53 $43 Million - $55.4 Million
-235,198 Reduced 99.5%
1,180 $236,000
Q1 2023

May 11, 2023
BUY
$182.66 - $235.53 $43 Million - $55.4 Million
235,215 Added 20224.85%
236,378 $236,000
Q4 2022

Feb 14, 2023
BUY
$185.53 - $241.31 $215,771 - $280,643
1,163 New
1,163 $276,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Gateway Advisory, LLC Portfolio

Follow Gateway Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email